bf/NASDAQ:RGNX_icon.jpeg

COM:REGENXBIO

REGENXBIO

  • Stock

USD

Last Close

9.18

22/11 21:00

Market Cap

529.01M

Beta: -

Volume Today

684.38K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
510K
-
1.40M
174.02%
3.55M
154.35%
5.53M
55.69%
6.10M
10.31%
8.49M
39.08%
14.63M
72.30%
16.33M
11.60%
6.95M
57.43%
average payables
317.50K
-
674K
112.28%
1.28M
89.69%
3.19M
149.32%
4.62M
45.00%
5.41M
17.06%
8.52M
57.39%
11.00M
29.23%
19.30M
75.38%
25.00M
29.53%
average receivables
1.49M
-
2.01M
35.29%
1.58M
21.15%
752.50K
52.49%
4.53M
501.99%
23.37M
415.84%
40.57M
73.63%
37.72M
7.04%
30.26M
19.77%
26.44M
12.64%
book value per share
-0.16
-
-0.43
165.89%
23.64
5,554.24%
6.12
74.09%
6.13
0.03%
15.22
148.50%
12.27
19.39%
10.13
17.42%
18.01
77.74%
11.96
33.58%
7.13
40.41%
capex per share
-0.06
-
-0.31
442.24%
-0.24
22.34%
-0.40
65.76%
-0.32
19.58%
-0.72
125.62%
-1.98
175.21%
-0.71
64.10%
-0.23
68.01%
capex to depreciation
-6.53
-
-14.98
129.58%
-2.67
82.20%
-3.33
25.09%
-1.64
50.86%
-3.20
95.03%
-8.80
175.38%
-2.38
72.96%
-0.58
75.84%
capex to operating cash flow
0.02
-
0.17
623.84%
0.12
26.43%
-0.13
202.77%
0.11
185.76%
0.50
356.75%
-0.38
177.38%
0.15
138.50%
0.05
69.20%
capex to revenue
-0.07
-
-1.78
2,481.33%
-0.69
61.20%
-0.06
91.18%
-0.33
447.40%
-0.17
47.74%
-0.18
2.95%
-0.27
52.30%
-0.11
59.51%
cash per share
0.09
-
0.09
0.18%
12.44
14,495.45%
3.39
72.75%
5.38
58.69%
9.57
77.77%
8.07
15.60%
12.76
58.06%
10.78
15.53%
8.45
21.61%
6.29
25.52%
days of inventory on hand
247.70
-
675.57
172.73%
1.14K
68.63%
217.11
80.94%
286.78
32.09%
107.36
62.56%
132.05
22.99%
93.01
29.56%
days payables outstanding
339.09
-
121.06
64.30%
246.25
103.41%
587.27
138.49%
1.03K
75.73%
167.05
83.81%
283.86
69.92%
108.56
61.76%
80.19
26.14%
182.10
127.10%
223.49
22.73%
days sales outstanding
65.24
-
112.24
72.05%
102.75
8.46%
82.08
20.11%
16.61
79.76%
14.34
13.65%
395.20
2,655.13%
101.54
74.31%
25.17
75.21%
90.93
261.21%
100.27
10.27%
debt to assets
0.69
-
0.01
-
0.02
110.73%
0.10
352.25%
0.08
24.15%
0.11
46.20%
0.16
36.74%
debt to equity
-0.42
-
0.01
-
0.03
118.08%
0.19
666.59%
0.11
41.03%
0.18
61.93%
0.29
55.96%
dividend yield
earnings yield
-0.01
-
-0.01
25.69%
-0.15
1,398.37%
-0.13
14.20%
-0.07
42.70%
0.07
196.76%
-0.06
188.43%
-0.07
4.39%
0.09
240.03%
-0.29
410.92%
-0.34
17.19%
enterprise value
399.27M
-
401.67M
0.60%
98.16M
75.56%
465.05M
373.78%
946.79M
103.59%
1.33B
40.74%
1.44B
8.44%
1.43B
1.36%
1.13B
20.77%
976.53M
13.52%
839.79M
14.00%
enterprise value over ebitda
-83.84
-
-109.99
31.18%
-4.25
96.13%
-7.12
67.35%
-12.05
69.24%
16.45
236.53%
-7.31
144.48%
-12.40
69.51%
7.03
156.68%
-3.72
152.94%
-3.13
15.80%
ev to operating cash flow
-132.56
-
-167.43
26.31%
-4.36
97.40%
-9.58
119.68%
-16.33
70.47%
12.73
178.00%
-13.42
205.36%
-26.36
96.52%
5.16
119.57%
-4.71
191.23%
-3.85
18.30%
ev to sales
65.59
-
65.63
0.06%
12.94
80.29%
101.34
683.41%
91.10
10.11%
6.10
93.31%
41.01
572.49%
9.22
77.52%
2.40
73.96%
8.66
260.85%
9.31
7.42%
free cash flow per share
-0.23
-
-0.18
20.35%
-2.51
1,276.50%
-2.15
14.50%
-2.18
1.55%
2.73
225.35%
-3.25
219.08%
-2.17
33.31%
3.17
246.21%
-5.52
273.92%
-5.22
5.41%
free cash flow yield
-0.01
-
-0.01
20.35%
-0.15
2,424.97%
-0.12
23.49%
-0.07
43.34%
0.07
199.35%
-0.08
221.93%
-0.05
39.76%
0.10
302.82%
-0.24
350.76%
-0.29
19.52%
graham net net
-0.21
-
-0.51
144.90%
12.17
2,505.00%
3.04
75.05%
4.96
63.24%
8.80
77.44%
7.64
13.15%
4.90
35.82%
3.34
31.99%
1.75
47.48%
0.72
58.72%
graham number
1.23
-
1.72
40.56%
36.37
2,010.75%
18.13
50.16%
18.37
1.36%
32.00
74.18%
26.70
16.57%
26.08
2.31%
34.94
33.95%
41.81
19.68%
31.09
25.66%
income quality
0.56
-
0.60
7.19%
0.99
64.70%
0.77
21.87%
0.79
2.78%
1.05
32.12%
1.14
8.58%
0.49
57.26%
1.71
252.33%
0.74
56.77%
0.83
11.98%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-7.82
-
-11.47
46.74%
-1.16K
9,985.52%
-154.65
-
6.09
103.94%
-11.30
285.68%
39.07
445.65%
interest debt per share
0.05
-
0.21
345.83%
0.00
98.95%
0.18
-
0.31
75.79%
1.97
539.75%
2.66
35.15%
2.74
2.78%
1.88
31.11%
inventory turnover
1.47
-
0.54
63.33%
0.32
40.70%
1.68
424.72%
1.27
24.30%
3.40
167.12%
2.76
18.70%
3.92
41.97%
invested capital
-0.42
-
0.01
-
0.03
118.08%
0.19
666.59%
0.11
41.03%
0.18
61.93%
0.29
55.96%
market cap
400.39M
-
400.39M
0%
152.27M
61.97%
489.89M
221.72%
993.44M
102.79%
1.40B
41.15%
1.50B
7.20%
1.69B
12.50%
1.39B
17.94%
978.69M
29.48%
785.03M
19.79%
net current asset value
-2.45M
-
-6.16M
151.76%
113.58M
1,944.37%
82.38M
27.47%
152.35M
84.94%
302.95M
98.85%
297.32M
1.86%
200.79M
32.47%
169.22M
15.72%
98.90M
41.55%
72.74M
26.45%
net debt to ebitda
0.23
-
-0.35
249.39%
2.34
767.93%
0.38
83.79%
0.59
56.14%
-0.86
244.93%
0.29
134.26%
2.31
684.48%
-1.61
169.59%
0.01
100.51%
-0.20
2,590.73%
net income per share
-0.41
-
-0.30
25.69%
-2.49
716.85%
-2.38
4.12%
-2.45
2.71%
2.99
222.08%
-2.58
186.36%
-2.98
15.57%
3.01
200.95%
-6.50
315.65%
-6.02
7.25%
operating cash flow per share
-0.23
-
-0.18
20.35%
-2.45
1,245.31%
-1.84
25.09%
-1.94
5.56%
3.13
261.29%
-2.94
193.77%
-1.45
50.60%
5.16
455.67%
-4.81
193.23%
-4.99
3.86%
payables turnover
1.08
-
3.01
180.09%
1.48
50.84%
0.62
58.07%
0.35
43.09%
2.18
517.77%
1.29
41.15%
3.36
161.48%
4.55
35.38%
2.00
55.97%
1.63
18.52%
receivables turnover
5.59
-
3.25
41.88%
3.55
9.24%
4.45
25.17%
21.97
394.13%
25.45
15.81%
0.92
96.37%
3.59
289.21%
14.50
303.36%
4.01
72.32%
3.64
9.31%
research and ddevelopement to revenue
0.83
-
0.81
2.31%
2.28
180.91%
9.91
335.24%
5.51
44.45%
0.38
93.03%
3.52
818.25%
1.08
69.48%
0.39
64.15%
2.15
457.58%
2.57
19.66%
return on tangible assets
-2.15
-
-1.15
46.57%
-0.10
91.01%
-0.36
253.78%
-0.37
1.03%
0.18
149.90%
-0.19
203.53%
-0.16
17.43%
0.11
173.06%
-0.34
393.12%
-0.46
36.46%
revenue per share
0.46
-
0.47
0.54%
0.83
77.73%
0.17
78.99%
0.35
100.18%
6.54
1,779.21%
0.96
85.31%
4.15
331.74%
11.08
167.32%
2.61
76.43%
2.06
21.01%
roe
2.51
-
0.70
72.05%
-0.11
114.98%
-0.39
270.03%
-0.40
2.68%
0.20
149.13%
-0.21
207.14%
-0.29
39.96%
0.17
156.80%
-0.54
424.67%
-0.85
55.64%
roic
2.48
-
1.20
51.58%
-0.11
108.88%
-0.40
276.96%
-0.42
4.31%
0.16
138.82%
-0.31
288.52%
-0.24
21.89%
0.15
164.55%
-0.37
341.12%
-0.55
46.95%
sales general and administrative to revenue
0.90
-
0.63
30.03%
1.57
149.48%
5.14
227.46%
2.62
49.03%
0.17
93.56%
1.47
772.03%
0.41
71.93%
0.17
59.15%
0.76
348.54%
0.98
29.62%
shareholders equity per share
-0.16
-
-0.43
165.89%
23.64
5,554.24%
6.12
74.09%
6.13
0.03%
15.22
148.50%
12.27
19.39%
10.13
17.42%
18.01
77.74%
11.96
33.58%
7.13
40.41%
stock based compensation to revenue
0.05
-
0.38
638.52%
1.53
298.01%
1.02
33.40%
0.08
92.54%
0.76
900.79%
0.21
72.88%
0.08
60.08%
0.36
338.54%
0.45
23.32%
tangible asset value
-2.14M
-
-5.70M
165.89%
216.81M
3,904.98%
161.74M
25.40%
183.03M
13.16%
508.85M
178.01%
450.20M
11.53%
377.75M
16.09%
764.30M
102.33%
516.20M
32.46%
311.74M
39.61%
tangible book value per share
-0.16
-
-0.43
165.89%
23.64
5,554.24%
6.12
74.09%
6.13
0.03%
15.22
148.50%
12.27
19.39%
10.13
17.42%
18.01
77.74%
11.96
33.58%
7.13
40.41%
working capital
-2.45M
-
-6.16M
151.76%
113.81M
1,948.15%
83.70M
26.45%
153.56M
83.46%
315.74M
105.61%
311.36M
1.39%
449.75M
44.45%
388.35M
13.65%
285.54M
26.47%
204.70M
28.31%

All numbers in USD (except ratios and percentages)